Leight G S, Wells S A, McCarty K S
Surgery. 1984 Mar;95(3):256-60.
The accurate determination of sex steroid receptors at the time of mastectomy (MX) for breast carcinoma is important for the determination of subsequent therapy of patients who develop metastases in inaccessible sites. The estrogen (E) and progesterone (P) receptor (R) proteins are heat labile, and measured levels may be vulnerable to alterations once the tumor is devascularized. To evaluate potential differences in ER and PR determinations in tumor tissue acquired at biopsy as compared with tumor from the MX specimen, quantitative analyses of ER (21 patients) and PR (17 patients) were performed on dual samples acquired from the initial biopsy (BX) and the subsequent MX specimen. Receptor concentrations were determined both by sucrose density gradient analysis and titration analysis, and results were expressed as fmol/mg cytosol protein. ER values were classified as receptor-rich (greater than 10 fmol/mg), intermediate (3 to 10 fmol/mg), or receptor-poor (less than 3 fmol/mg); PR values greater than 3 fmol/mg were considered positive. ER BX values were found to be rich or intermediate in 18 patients. When compared with BX values, MX ER values were quantitatively unchanged in 11 patients, lower (MX less than BX) in four patients, and higher in three patients (MX greater than BX). In no patient was the BX ER rich or intermediate and the concomitant MX ER poor. In two patients the PR value was "positive" at BX but "negative" at MX. Accordingly, malignant tissue from a pre-MX biopsy specimen is preferred for receptor analysis although it is apparent that tumor tissue from a properly handled MX specimen is satisfactory for the determination of ER status for clinical purposes.
在乳腺癌乳房切除术(MX)时准确测定性类固醇受体,对于确定那些在难以触及部位发生转移的患者的后续治疗非常重要。雌激素(E)和孕激素(P)受体(R)蛋白对热不稳定,一旦肿瘤血管被阻断,所测水平可能容易发生改变。为了评估活检获取的肿瘤组织与MX标本中的肿瘤在雌激素受体(ER)和孕激素受体(PR)测定方面的潜在差异,对从初始活检(BX)和随后的MX标本获取的双份样本进行了ER(21例患者)和PR(17例患者)的定量分析。通过蔗糖密度梯度分析和滴定分析确定受体浓度,结果以每毫克胞浆蛋白中的飞摩尔数表示。ER值分为富含受体(大于10飞摩尔/毫克)、中等(3至10飞摩尔/毫克)或缺乏受体(小于3飞摩尔/毫克);PR值大于3飞摩尔/毫克被认为是阳性。发现18例患者的ER BX值为富含或中等水平。与BX值相比,11例患者的MX ER值在数量上无变化,4例患者较低(MX小于BX),3例患者较高(MX大于BX)。没有患者的BX ER为富含或中等水平而同时MX ER为缺乏水平。2例患者的PR值在BX时为“阳性”但在MX时为“阴性”。因此,尽管显然妥善处理的MX标本中的肿瘤组织用于临床目的的ER状态测定是令人满意的,但MX前活检标本中的恶性组织更适合用于受体分析。